Life Sciences Wins And Expanded Sales Will Open Future Markets

AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Published
29 Mar 25
Updated
24 Jul 25
AnalystConsensusTarget's Fair Value
CA$8.15
30.9% undervalued intrinsic discount
24 Jul
CA$5.63
Loading
1Y
27.4%
7D
-1.6%

Author's Valuation

CA$8.2

30.9% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 1.33%

Shared on24 Apr 25
Fair value Decreased 8.02%

AnalystConsensusTarget has increased shares outstanding growth rate from 0.1% to 0.1%.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 9.51%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25